Wednesday, 9 August 2017

Dairy Products as Source of Angiotensin-I-Converting Enzyme-Inhibitory (Ace-I) Peptides

Dairy Products

The nutraceutical benefits derived from the protein component of dairy products on human health are now widely acknowledged. These are the result of the close association between milk protein quality and proteolytic activity of starter and non-starter bacteria, which leads to generation of secondary metabolites with healthpromoting properties.

Lactic acid bacteria (LAB) such as Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus and probiotics such as Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum are commonly used as starter cultures in the dairy industry.

The proteolytic activity of these LABS along with non-starter LAB, naturally present in milk, generates peptides with a wide array of biological activities, including antihypertensive, antithrombotic, opioid, immunomodulatory, antimicrobial, and antioxidant activities.

No comments:

Post a Comment